Insufficient documentation of prior medication trials is the most common TMS denial cause. Beyond that, payers disagree on almost everything: which rating scales qualify, how long an adequate trial runs, whether a psychotherapy trial is required, and how long an authorization lasts. Winning packets match each payer's counting rules before submission, not on appeal.

Higher first-pass PA approval
Reauths ready before coverage lapses
An audit-ready documentation trail

Evidence to catch before work leaves the queue.

Rules-first automation with human review where it counts.

Inspect the actual artifacts.

Foresight checks whether required evidence is present, whether records contradict each other, and whether the available facts look approvable under payer criteria before submission.

Completeness

Verify each medication trial carries drug, dates, dose reached, and discontinuation reason; check rating-scale baseline recency, psychotherapy-trial evidence where the payer requires it, contraindication screening, PDMP checks, REMS enrollment, and observation documentation before the packet is drafted.

Contradictions

Flag trial histories that conflict with pharmacy fill data, session ledgers that do not match 90867/90868/90869 usage, Spravato units that disagree with the documented dose, monotherapy patients routed to a payer that still requires a concurrent oral antidepressant, or an auth issued under a retired drug code.

Payer approvability

Apply each payer's counting rules — adequate-trial duration and class requirements, accepted rating scales, current-episode and recency windows, psychotherapy-trial expectations, and improvement thresholds for repeat courses — before a high-cost episode is scheduled.

Leakage points Foresight surfaces early.

Prior trials documented as narrative instead of drug, dates, dose, and outcome

A rating scale the payer does not accept, or a baseline outside its recency window

Authorized sessions exhausted or auth expired before reauthorization starts

A drug-code transition (S0013 to J0013) a payer treats as a new authorization

Map the risk surface.

A useful audit scores concrete workflow gaps: missing evidence, contradictory records, payer criteria risk, and follow-through after submission.

Required evidence present

Whether the claim, PA, or appeal has the basic identifiers and clinical anchors needed before work leaves the queue.

Chart contradictions

Where the EHR, notes, questionnaire, inventory, pharmacy response, and billing record point to different answers.

Payer approvability

Whether the available evidence appears to satisfy payer criteria before the submission creates AR or appeal work.

Follow-through

Whether approvals, denials, paper EOBs, portal messages, corrected claims, and deposits resolve cleanly after submission.

See how Foresight would inspect this workflow.

Book demo